ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Journal of Chromatography B
Volume 808, Issue 2, 5 September 2004, Pages 153-161
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (533 K)

Article Toolbox
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
Special issue
View Record in Scopus
 
doi:10.1016/j.jchromb.2004.05.005    
How to Cite or Link Using DOI (Opens New Window)

Copyright © 2004 Elsevier B.V. All rights reserved.

Unified gas chromatographic–mass spectrometric method for quantitating tyrosine metabolites in urine and plasma

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Albert L. Shroadsa, George N. HendersonCorresponding Author Contact Information, E-mail The Corresponding Author, a, Jang Cheunga, Margaret O. Jamesc and Peter W. Stacpoolea, b

a Division of Endocrinology and Metabolism, Department of Medicine, University of Florida, Gainesville, FL 32610, USA

b Department of Biochemistry and Molecular Biology, Colleges of Medicine, University of Florida, Gainesville, FL 32610, USA

c Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA


Received 28 November 2003; 
Revised 7 May 2004; 
accepted 10 May 2004. 
Available online 7 June 2004.

Abstract

Tyrosine and many of its catabolites play significant roles in the in the toxicity associated with acquired and congenital forms of hypertyrosinemia. We now report a specific and sensitive GC/MS method for the simultaneous determination of tyrosine metabolites maleylacetone (MA), fumarylacetone (FA), succinylacetone (SA), fumarate and acetoacetate in urine and plasma. Tyrosine metabolites and an internal standard, 2-oxohexanoic acid (OHA), in urine or plasma samples were derivatized to their methyl esters with a 12% boron trifluoride–methanol complex (12%BF3–MeOH). The reaction mixture was extracted with methylene chloride and analyzed by GC/MS, using a selected ion monitoring (SIM) mode. The detection limits were in the range of 0.08–0.4 ng and the quantitation limits were 0.2–2 ng. Most of the intraday and interday coefficients of variation for three concentrations (low, medium and high) of the analytes were below 10%. Sensitivity and selectivity are superior to existing HPLC or enzymatic methods and derivatization of samples is simpler than the traditional silylation of organic acids used for analysis by GC/MS or derivatization to oximes, followed by silylation in the case of the ketoacids, such as SA. Furthermore, the current procedure can be performed in aqueous solution, which results in a high percentage yield without appreciable analyte degradation or formation of side products. Thus far, the method has been successfully applied in the analysis of over 5000 urine and plasma samples from humans and rodents.

Author Keywords: Tyrosinemia; Tyrosine; Maleylacetone; Fumarylacetone; Succinylacetone; Fumarate; Nitisione

Article Outline

1. Introduction
2. Experimental
2.1. Materials
2.2. Samples
2.3. Derivatization and extraction
2.4. GC/MS conditions
2.5. Calibration curves
2.6. Recovery of derivatization and extraction
2.7. Method validation
2.8. Sensitivity
3. Results
3.1. Representative total ion chromatograms (TIC) and SIMs
3.2. Accuracy and precision
3.3. Sensitivity and recovery of derivatization and extraction
3.4. Application of the method for the analysis of urine and plasma samples
4. Discussion
Acknowledgements
References







Corresponding Author Contact InformationCorresponding author. Tel.: +1 352 392 6193; fax: +1 352 846 0990.


Journal of Chromatography B
Volume 808, Issue 2, 5 September 2004, Pages 153-161
 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.